Day: July 8, 2020

HOUSTON, July 08, 2020 (GLOBE NEWSWIRE) — Harvest Oil & Gas Corp. (OTCQX: HRST) (“Harvest” or the “Company”) announced today that a wholly-owned subsidiary has entered into a definitive agreement to sell its Appalachian Basin assets, which will represent substantially all of the assets of the Company, to an unaffiliated third party (“Buyer”) for consideration of $20.5 million, subject to customary purchase price adjustments. The consideration consists of $14.5 million of cash and a $6 million note.  The transaction is expected to close in August 2020 and has an effective date of July 1, 2020. The holders of a majority of the common stock of the Company have approved the transaction. The definitive agreement contains various representations, warranties, covenants and indemnification obligations of the Company and the Buyer that...

NEW YORK and CLEVELAND, July 08, 2020 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced recent updates on its clinical programs, highlighted by the restart of patient enrollment in the Company’s pivotal Phase 3 VIITAL™ study of EB-101, its autologous, gene-corrected cell therapy, for the treatment of recessive dystrophic epidermolysis bullosa (RDEB). Enrollment in the VIITAL™ study at Stanford University Medical Center was paused in March 2020 in order to redirect healthcare resources to COVID-19 patients and to ensure the safety of study participants and site staff.“RDEB is a debilitating and life-threatening rare genetic disorder without an approved treatment option. Reinitiating enrollment in the VIITAL study is important for patients with RDEB and...

DALLAS, July 08, 2020 (GLOBE NEWSWIRE) — Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) an SEC fully-reporting, growth-oriented company focused on manufacturing and marketing aerosol delivery systems based on pressurized Metered Dose Inhaler (MDI) technology, announced today that it has delivered an initial 2,000 units under its previously announced 100,000 unit order.Rapid Therapeutic Science Laboratories, Inc. Chairman and CEO, Donal R. Schmidt, Jr. stated, “RTSL is moving forward on its first major wholesale contract. We have completed the first shipment totaling 2,000 units of our proprietary CBD/CBG formula under our white label order of 100,000 units we previously announced. These MDIs are currently being sold through doctors’ offices and in pharmacies across the United States. The initial lot of 2,000 was presold...

TORONTO, July 08, 2020 (GLOBE NEWSWIRE) — Marathon Gold Corporation (“Marathon” or the “Company”; TSX: MOZ) is pleased to announce the appointment of Mr. Tim Williams as Chief Operating Officer, effective July 13, 2020.Mr. Williams is a professional engineer with over 25 years of experience in mine construction and operation. Between 2011 and 2016 he served as VP Operations for Rio Alto Mining Inc. and subsequently Tahoe Resources Inc., during which time he was responsible for the construction, ramp-up and successful operation of the La Arena Gold Mine in Peru and the construction of the nearby Shahuindo Gold Mine. La Arena and Shahuindo are currently operated by Pan American Silver Corporation.Prior to Rio Alto, Mr. Williams served in a series of progressively more senior technical and project management roles including at the...

Patent coverage for CM24 now extends to the U.S. and the EUTEL AVIV, Israel, July 08, 2020 (GLOBE NEWSWIRE) — Kitov Pharma Ltd. (“Kitov”) (NASDAQ/TASE: KTOV), a clinical-stage company advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, today announced receipt of a notification from the European Patent Office to grant a patent for Kitov’s application entitled “Humanized antibodies against CEACAM1.” The patent covers protein and DNA sequences pertaining to humanized antibodies capable of specific binding to human CEACAM1 molecules, including its lead monoclonal antibody, CM24, pharmaceutical compositions comprising these antibodies, as well as methods for their use in treating and diagnosing cancer and other conditions.Kitov is currently advancing preparations to initiate a Phase 1/2 clinical trial...

If approved, aducanumab would be the first treatment with the potential to meaningfully change the course of Alzheimer’s diseaseCAMBRIDGE, Mass. and TOKYO, July 08, 2020 (GLOBE NEWSWIRE) — Biogen (Nasdaq: BIIB) and Eisai Co., Ltd. (Tokyo, Japan) today announced that Biogen has completed the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the approval of aducanumab, an investigational treatment for Alzheimer’s disease. The completed submission followed ongoing collaboration with the FDA and includes clinical data from the Phase 3 EMERGE and ENGAGE studies, as well as the Phase 1b PRIME study. As part of the completed submission, Biogen has requested Priority Review. If approved, aducanumab would become the first therapy to reduce the clinical decline of Alzheimer’s disease and...

Philadelphia, PA, July 08, 2020 (GLOBE NEWSWIRE) — VSBLTY Groupe Technologies Corp. (CSE: VSBY) (Frankfurt: 5VS) (OTC:VSBGF) (“VSBLTY”), a leading provider of security and retail marketing technology, announced today the signing of an agreement with Synect, a digital strategy and content creation agency that enables video displays of unlimited size and scale in airports throughout the country.The announcement was made by VSBLTY Co-founder and CEO Jay Hutton, who said the contract is valued at up to $1,360,000 USD over the next three years. That projection is based on Synect’s current book of business and does not include additional clients that Synect may add in the future. “We are delighted to partner with Synect that has earned an outstanding reputation for its content and creative capabilities and that has mastered the art and...

DRAPER, Utah, July 08, 2020 (GLOBE NEWSWIRE) — HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), today announced that that it has commenced an underwritten public offering of $250 million of shares of its common stock. HealthEquity intends to use the net proceeds from the offering to free up additional capital for organic and inorganic growth by pre-paying $200 million under its term loan facility, with the remaining proceeds to be used for general corporate purposes, which may include additional pre-payments under its term loan facility and/or potential acquisitions.Wells Fargo Securities, LLC and J.P. Morgan Securities LLC are acting as lead book-running managers for the offering. Goldman Sachs & Co. LLC, and RBC Capital Markets LLC are acting as book-running managers for the offering. The offering is being...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, July 08, 2020 (GLOBE NEWSWIRE) — Global Care Capital Inc. (CSE:HLTH, FRANKFURT: L6V1) (the “Company” or “Global Care”) a global investment company which engages in early stage investment opportunities in private and public companies, is pleased to announce that its portfolio company High Standard Health Care Ltd. (“High Standard Health Care”) has, pursuant to entering into an Approved Vendor Contract on July 6th, 2020, become an Approved Vendor for Nevada based long term care facility, Alta Skilled Nursing and Rehab Centre (“Alta”) https://www.altanursingandrehab.com/.High Standard Health Care specializes in procuring personal protective equipment (“PPE”) including but not limited to respiratory masks, hand...

VANCOUVER, British Columbia, July 08, 2020 (GLOBE NEWSWIRE) — Abacus Mining & Exploration Corporation (“Abacus” or the “Company”) (TSXV: AME) is pleased to provide an update regarding ongoing work undertaken on its Jersey Valley gold property, within the Battle Mountain trend of northern Nevada.The Company has been delayed in implementing a previously planned field program due to closures, travel restrictions and other effects of the COVID 19 pandemic. In its place, the Company has taken the time to locate and acquire the raw magnetic and IP geophysics done over Jersey Valley by a previous operator. This data has now been fully reprocessed by JL Wright Geophysics, and it shows the presence of compelling untested drill targets.Jersey Valley is underlain by an uplifted range of sediments and intrusives to the east and an extensive...